Qualigen Therapeutics Stockholders Approve Reverse Stock Split and Share Issuance to Alpha Capital at Annual Meeting

AIxCrypto Holdings, Inc.

All five director nominees elected, each receiving over 14.3 million votes.
Ratification of WithumSmith+Brown as auditor approved with 17,030,627 votes in favor.
Reverse stock split (10:1 to 50:1) approved with 16,165,754 votes for, 1,435,884 against.
Issuance of >20% common stock to Alpha Capital Anstalt approved with 14,562,299 votes for, 347,563 against, 18,595 abstaining.
Advisory vote on executive compensation approved with 14,540,812 votes for, 297,422 against, 90,223 abstaining.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.